Source: Annual Congress 2001 - COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Corkovic, D. Begovic, L. Nagorni-Obradovic, S. Ignjatovic (Belgrade, Kragujevac, Yugoslavia). Serum ascorbid acid concentration in COPD patients with partial and with complete respiratory failure. Eur Respir J 2001; 16: Suppl. 31, 1464

Member's Comments

No comment yet.

Related content which might interest you: Serum ascorbic acid concentration in patients with acute pneumonia and in COPD patients with and without respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004 Serum uric acid levels among patients with COPD exacerbations Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Serum uric acid levels among COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 435s Year: 2003 Plasma amino acid profiles in patients of various respiratory disorders Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges Year: 2010 Assessment of serum uric acid in COPD exacerbations Source: International Congress 2017 – Markers of COPD progression Year: 2017 Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD) Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung Year: 2020 Serum levels of hyaluronic acid are associated with COPD severity and predict survival Source: Eur Respir J, 53 (3) 1801183; 10.1183/13993003.01183-2018 Year: 2019 Blood plasma levels of ascorbic acid in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Serum uric acid as a predictor of mortality and future exacerbations of COPD Source: Eur Respir J 2014; 43: 43-53 Year: 2004 Muscle energy metabolism and plasma amino acids level in patients with chronic respiratory impairment Source: Eur Respir J 2002; 20: Suppl. 38, 289s Year: 2002 Urinary uric acid excretion and overnight change in the urinary uric acid: creatinin ratio as a marker of tissue hypoxia in patients with COPD and OSA Source: Eur Respir J 2006; 28: Suppl. 50, 408s Year: 2006 Serum uric acid and uric acid/creatinine ratio in exacerbations of COPD Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Does serum uric acid levels predict in-hospital mortality in severe COPD exacerbations? Source: International Congress 2015 – COPD: interesting notes Year: 2015 Siccine acid effects in patients with exacerbation of severe COPD Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 The prognostic value of elevated levels of troponin I (Tn I) and heart-type fatty acid binding protein (H-FABP) in hospitalized COPD patients with acute respiratory failure (ARF) Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Higher serum lactic deydrogenase (LDH) levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure (CPAP) Source: Eur Respir J 2004; 24: Suppl. 48, 92s Year: 2004